Delivery Order SPE2DB20D3101-SPE2DB25FRUK8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,181.76 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a competitively awarded contract with no set-aside designation. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,207.79 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors. The contract, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a child delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors, with a contract ceiling value of $47,910.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $14,014.80 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 19, 2025. The contract employs firm fixed price terms with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $24,386.37 delivery order for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $25,796.39 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of August 20, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial pharmaceutical supply relationship with DLA, supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $35,870.18 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, executed on August 15, 2025, with an ultimate completion date of August 18, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $4,786.59 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $22,390.62 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the Defense...
- The Defense Logistics Agency awarded a delivery order valued at approximately $15,000 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUK8Delivery Order
The Defense Logistics Agency awarded a $34,017.92 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors under a firm fixed-price contract on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting military healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and fulfill this order through its established role as a critical pharmaceutical distributor for federal medical supply chains. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency and U.S. Coast Guard. The company was competitively selected for this contract vehicle, demonstrating its capability to meet federal procurement requirements and serve as a major pharmaceutical vendor supporting defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 9/4/25 |